About ThromboVision
ThromboVision is a company based in Houston (United States) founded in 2005. It operates as a B2B. ThromboVision has raised $4 million across 2 funding rounds from investors including SVB and National Healthcare Services. ThromboVision operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Microvisk, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4 M (USD)
in 2 rounds
-
Latest Funding Round
$4 M (USD), Series A
Sep 13, 2007
-
Investors
SVB
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ThromboVision
ThromboVision has successfully raised a total of $4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in September 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ThromboVision
ThromboVision has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include SVB and National Healthcare Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Banking services are provided to innovative companies, investors, and individuals.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for ThromboVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ThromboVision
Investment portfolio details for ThromboVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ThromboVision
Detailed financials for ThromboVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thrombovision Comparisons
Peer comparison for ThromboVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ThromboVision
ThromboVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Microvisk, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Near-patient diagnostic systems for coagulation testing are developed.
|
|
| Locked | Locked | Locked |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| Locked | Locked | Locked |
Smart diagnostics devices for blood coagulation analysis are developed.
|
|
| Locked | Locked | Locked |
Hemostasis and fluid replacement products are provided for medical applications.
|
|
| Locked | Locked | Locked |
Handheld devices for blood clot monitoring are provided by Microvisk.
|
|
| Locked | Locked | Locked |
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
Detailed competitors of ThromboVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thrombovision
Complete news archive for ThromboVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ThromboVision
ThromboVision was founded in 2005 and raised its 1st funding round 2 years after it was founded.
ThromboVision is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
ThromboVision is a funded company, having raised a total of $4M across 2 funding rounds to date.
ThromboVision offers point-of-care diagnostic products for hematology through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and hematology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
ThromboVision's top competitors include Accriva Diagnostics, Diagnostica Stago and Enzyre.
ThromboVision has 2 investors. Key investors include SVB, and National Healthcare Services.